Exact Mass: 302.1647

Exact Mass Matches: 302.1647

Found 236 metabolites which its exact mass value is equals to given mass value 302.1647, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glycerol tributanoate

1,3-bis(butanoyloxy)propan-2-yl butanoate

C15H26O6 (302.1729)


Flavouring agent. Glycerol tributanoate is found in many foods, some of which are durian, canola, conch, and italian sweet red pepper. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Glycerol tributanoate is a flavouring agent

   

Farnesyl phosphate

trans,trans-Farnesyl phosphate

C15H27O4P (302.1647)


   

Arginylglutamine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702)


Arginylglutamine is a dipeptide composed of arginine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylarginine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-5-carbamimidamidopentanoate

C11H22N6O4 (302.1702)


Glutaminylarginine is a dipeptide composed of glutamine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Neuromedin B (1-3)

(2R)-2-{[(2S)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-4-methylpentanoate

C12H22N4O5 (302.159)


NMB acts by binding to its high affinity cell surface receptor, neuromedin B receptor (NMBR). This receptor is a G protein-coupled receptor with seven transmembrane spanning regions, hence the receptor is also denoted as a 7 transmembrane receptor (7-TMR). Upon binding several intracellular signaling pathways are triggered (see Figure 2). Neuromedin B (NMB) is a bombesin-related peptide in mammals. It was originally purified from pig spinal cord, and later shown to be present in human central nervous system and gastrointestinal tract. This structure shows the 1-3 fragment of neuromedin B. NMB acts by binding to its high affinity cell surface receptor, neuromedin B receptor (NMBR). This receptor is a G protein-coupled receptor with seven transmembrane spanning regions, hence the receptor is also denoted as a 7 transmembrane receptor (7-TMR). Upon binding several intracellular signaling pathways are triggered (see Figure 2).; Neuromedin B (NMB) is a bombesin-related peptide in mammals. It was originally purified from pig spinal cord, and later shown to be present in human central nervous system and gastrointestinal tract.

   

Arginyl-Gamma-glutamate

2-Amino-4-[(2-amino-5-carbamimidamidopentanoyl)-C-hydroxycarbonimidoyl]butanoate

C11H22N6O4 (302.1702)


Arginyl-Gamma-glutamate is a dipeptide composed of arginine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

DL-Valine-4-antipyrineamide

2-Amino-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methylbutanimidate

C16H22N4O2 (302.1743)


   

Emivirine

6-benzyl-1-(ethoxymethyl)-5-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

C17H22N2O3 (302.163)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

1,1,1-Tri(butyryloxy)propane

1,1-Bis(butanoyloxy)propyl butanoic acid

C15H26O6 (302.1729)


   

tributyrylglycerol

5-butanoyl-5,6-dihydroxy-6-(hydroxymethyl)decane-4,7-dione

C15H26O6 (302.1729)


   

trichostatin A

N-Hydroxy7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidate

C17H22N2O3 (302.163)


   

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

N-Hydroxy7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-3,5-dienimidate

C17H22N2O3 (302.163)


   

13-Acetoxyanagyrine

13-Acetoxyanagyrine

C17H22N2O3 (302.163)


   
   
   

2,4-Bis(1-phenylethyl)phenol

2,4-Bis(1-phenylethyl)phenol

C22H22O (302.1671)


   
   

Trichostatin A S-isomer

Trichostatin A S-isomer

C17H22N2O3 (302.163)


   

3-isobutyrylamino-1-phenethyl-piperidine-2,6-dione

3-isobutyrylamino-1-phenethyl-piperidine-2,6-dione

C17H22N2O3 (302.163)


   

rosiridoside A

rosiridoside A

C15H26O6 (302.1729)


   

Sulfoorientalol A

Sulfoorientalol A

C15H26O4S (302.1552)


   
   

2,6-bis(1-phenylethyl)phenol

2,6-bis(1-phenylethyl)phenol

C22H22O (302.1671)


   

leptoclinidamide trifluoroacetic acid salt

leptoclinidamide trifluoroacetic acid salt

C16H22N4O2 (302.1743)


   

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

C15H26O6 (302.1729)


   

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   
   
   
   
   
   
   
   
   
   
   
   

alanylglycylarginine

alanylglycylarginine

C11H22N6O4 (302.1702)


   
   
   

glycylalanylarginine

glycylalanylarginine

C11H22N6O4 (302.1702)


   
   
   
   
   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1743)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

C16H22N4O2 (302.1743)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

C16H22N4O2 (302.1743)


   

Tributyrin (C4:0)

Tributyrin (C4:0)

C15H26O6 (302.1729)


   

butyrin

Glyceryl tributyrate

C15H26O6 (302.1729)


A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by butyric acid. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer

   

Ala Ala Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]propanamido]propanoic acid

C12H22N4O5 (302.159)


   

Ala Gly Gly Val

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-3-methylbutanoic acid

C12H22N4O5 (302.159)


   

Ala Gly Val Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-methylbutanamido]acetic acid

C12H22N4O5 (302.159)


   

Ala Val Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]acetamido}acetic acid

C12H22N4O5 (302.159)


   

Gly Ala Gly Val

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-3-methylbutanoic acid

C12H22N4O5 (302.159)


   

Gly Ala Val Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-methylbutanamido]acetic acid

C12H22N4O5 (302.159)


   

Gly Gly Ala Val

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-3-methylbutanoic acid

C12H22N4O5 (302.159)


   

Gly Gly Gly Ile

(2S,3S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-3-methylpentanoic acid

C12H22N4O5 (302.159)


   

Gly Gly Gly Leu

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-4-methylpentanoic acid

C12H22N4O5 (302.159)


   

Gly Gly Ile Gly

2-[(2S,3S)-2-[2-(2-aminoacetamido)acetamido]-3-methylpentanamido]acetic acid

C12H22N4O5 (302.159)


   

Gly Gly Leu Gly

2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-methylpentanamido]acetic acid

C12H22N4O5 (302.159)


   

Gly Gly Val Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-methylbutanamido]propanoic acid

C12H22N4O5 (302.159)


   

Gly Ile Gly Gly

2-{2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]acetamido}acetic acid

C12H22N4O5 (302.159)


   

Gly Leu Gly Gly

2-{2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]acetamido}acetic acid

C12H22N4O5 (302.159)


   

Gly Val Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]propanamido]acetic acid

C12H22N4O5 (302.159)


   

Gly Val Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]acetamido}propanoic acid

C12H22N4O5 (302.159)


   

Ergoline-1,8-dimethanol, 10-methoxy-, (8b)-

Ergoline-1,8-dimethanol, 10-methoxy-, (8b)-

C17H22N2O3 (302.163)


   
   
   

Ile Gly Gly Gly

2-(2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}acetamido)acetic acid

C12H22N4O5 (302.159)


   
   
   
   

Leu Gly Gly Gly

2-(2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}acetamido)acetic acid

C12H22N4O5 (302.159)


   
   
   
   
   
   
   
   
   
   
   

Val Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]acetamido}acetic acid

C12H22N4O5 (302.159)


   

Val Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}propanamido]acetic acid

C12H22N4O5 (302.159)


   

Val Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}acetamido)propanoic acid

C12H22N4O5 (302.159)


   

Trichostatin A

7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6R-dimethyl-7-oxo-2E,4E-heptadienamide

C17H22N2O3 (302.163)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC[1].

   

α-hydroxy Farnesyl Phosphonic Acid

(±)-1-hydroxy-3,7,11-trimethyl-2E,6E,10-dodecatriene-1-phosphonic acid

C15H27O4P (302.1647)


   

Arg-GLN

2-(2-amino-4-carbamoylbutanamido)-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702)


A dipeptide formed from L-arginyl and L-glutamine residues.

   

Arg-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702)


   

GLN-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702)


   

GGlu-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H22N6O4 (302.1702)


   

FOH 22:12

(4Z,19Z)-docosa-4,19-diene-2,9,11,13,21-pentayne-1-ol

C22H22O (302.1671)


   

ascr#3

8R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-2E-nonenoic acid

C15H26O6 (302.1729)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,8R)-8-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#2, ascr#4, and ascr#8 in male attraction.

   

oscr#3

9-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-nonenoic acid

C15H26O6 (302.1729)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-9-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   
   

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

1-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4-piperidine]

1-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4-piperidine]

C17H22N2O3 (302.163)


   

Nortriptyline-d3 hydrochloride

Nortriptyline-d3 hydrochloride

C19H19ClD3N (302.1629)


   

Cyclizine Hydrochloride

Cyclizine Hydrochloride

C18H23ClN2 (302.155)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

C16H22N4O2 (302.1743)


   
   

2-({2,2-Bis[(oxiran-2-ylmethoxy)methyl]butoxy}methyl)oxirane

1-(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane

C15H26O6 (302.1729)


   

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

C15H26O6 (302.1729)


   

(S)-BENZYL 2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBOXYLATE

(S)-BENZYL 2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBOXYLATE

C17H22N2O3 (302.163)


   

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

Benzyl 4-(2-oxopyrrolidin-1-yl)piperidine-1-carboxylate

Benzyl 4-(2-oxopyrrolidin-1-yl)piperidine-1-carboxylate

C17H22N2O3 (302.163)


   

H-Ala-Ala-Ala-Ala-OH

H-Ala-Ala-Ala-Ala-OH

C12H22N4O5 (302.159)


   

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

C22H22O (302.1671)


   

Desipramine hydrochloride

Desipramine hydrochloride

C18H23ClN2 (302.155)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators D004791 - Enzyme Inhibitors

   

(3aR,6S,6aR)-6-({[Dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)- 2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one (non-preferr ed name)

(3aR,6S,6aR)-6-({[Dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)- 2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one (non-preferr ed name)

C14H26O5Si (302.1549)


   

Cyclizine dihydrochloride

Cyclizine dihydrochloride

C18H23ClN2 (302.155)


   

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

C16H22N4O2 (302.1743)


   

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

C15H26O6 (302.1729)


   

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

C15H26O6 (302.1729)


   

3-[(2S)-2-[3-(cyclopropylmethoxy)-4-methoxyphenyl]propyl]-1H-imidazol-2-one

3-[(2S)-2-[3-(cyclopropylmethoxy)-4-methoxyphenyl]propyl]-1H-imidazol-2-one

C17H22N2O3 (302.163)


   

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

C16H22N4O2 (302.1743)


   

(3aR,6R,6aR)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxol-4-one

(3aR,6R,6aR)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxol-4-one

C14H26O5Si (302.1549)


   

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

(s)-1-[(r)-2-methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-2-methyl-piperazine

(s)-1-[(r)-2-methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-2-methyl-piperazine

C15H21F3N2O (302.1606)


   

aluminum di(sec-butoxide)acetoacetic ester chelate

aluminum di(sec-butoxide)acetoacetic ester chelate

C14H27AlO5 (302.1674)


   

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

C14H18N4.C2H4O2 (302.1743)


   

tert-butyl (1r,3r)-1-(4-cyanophenyl)-3-hydroxy-3-MethylcyclobutylcarbaMate

tert-butyl (1r,3r)-1-(4-cyanophenyl)-3-hydroxy-3-MethylcyclobutylcarbaMate

C17H22N2O3 (302.163)


   

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

C11H22N6O4 (302.1702)


   

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689)


   

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689)


   

(R)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate

(R)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate

C17H22N2O3 (302.163)


   
   

7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide

7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide

C17H22N2O3 (302.163)


   

N-(4-morpholinobutyl)benzofuran-2-carboxamide

N-(4-morpholinobutyl)benzofuran-2-carboxamide

C17H22N2O3 (302.163)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

C15H26O6 (302.1729)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1743)


   

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

C11H22N6O4 (302.1702)


   

2-[(E)-(4-methylpiperazino)methyleneamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carbonitrile

2-[(E)-(4-methylpiperazino)methyleneamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carbonitrile

C16H22N4S (302.1565)


   
   

N-(N2-L-Alanyl-L-arginyl)glycine

N-(N2-L-Alanyl-L-arginyl)glycine

C11H22N6O4 (302.1702)


   

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

C11H22N6O4 (302.1702)


   

Emivirine

Emivirine

C17H22N2O3 (302.163)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

C17H22N2O3 (302.163)


   

[3-carboxy-2-[(E)-6-carboxyhex-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-6-carboxyhex-4-enoyl]oxypropyl]-trimethylazanium

C14H24NO6+ (302.1604)


   

[3-carboxy-2-[(E)-6-carboxyhex-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-6-carboxyhex-2-enoyl]oxypropyl]-trimethylazanium

C14H24NO6+ (302.1604)


   

[3-carboxy-2-[(E)-3-carboxy-4-methylpent-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-3-carboxy-4-methylpent-2-enoyl]oxypropyl]-trimethylazanium

C14H24NO6+ (302.1604)


   

Desipramine Hcl

Desipramine Hcl

C18H23ClN2 (302.155)


   

N-cyclohexyl-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide

N-cyclohexyl-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide

C17H22N2O3 (302.163)


   
   

Rosanilin(1+)

Rosanilin(1+)

C20H20N3+ (302.1657)


   

N-(5-tert-butyl-2-methoxyphenyl)-3,5-dimethyl-4-isoxazolecarboxamide

N-(5-tert-butyl-2-methoxyphenyl)-3,5-dimethyl-4-isoxazolecarboxamide

C17H22N2O3 (302.163)


   

3-[(3,3-dimethyl-1-oxobutyl)amino]-1H-indole-2-carboxylic acid ethyl ester

3-[(3,3-dimethyl-1-oxobutyl)amino]-1H-indole-2-carboxylic acid ethyl ester

C17H22N2O3 (302.163)


   
   
   
   
   
   
   
   
   

1-[2-[2-(2-Methoxy-6-prop-2-enylphenoxy)ethoxy]ethyl]imidazole

1-[2-[2-(2-Methoxy-6-prop-2-enylphenoxy)ethoxy]ethyl]imidazole

C17H22N2O3 (302.163)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl dihydrogen phosphate

[(1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl dihydrogen phosphate

C15H27O4P (302.1647)


   

2,6-DI(alpha-Methylbenzyl(5D))phenol

2,6-DI(alpha-Methylbenzyl(5D))phenol

C22H22O (302.1671)


   

Arginyl-glutamine

Arginyl-glutamine

C11H22N6O4 (302.1702)


   

Glutaminyl-arginine

Glutaminyl-arginine

C11H22N6O4 (302.1702)


   

Neuromedin B (1-3)

Neuromedin B (1-3)

C12H22N4O5 (302.159)


   

Arginyl-Gamma-glutamate

Arginyl-Gamma-glutamate

C11H22N6O4 (302.1702)


   

ascaroside C9

ascaroside C9

C15H26O6 (302.1729)


   

glutaminylarginine

glutaminylarginine

C11H22N6O4 (302.1702)


   

(2E,6E)-farnesyl monophosphate

(2E,6E)-farnesyl monophosphate

C15H27O4P (302.1647)


A member of the class of farnesyl phosphates that is the monophosphatr derivative of (2E,6E)-farnesol

   
   

TG 4:0/4:0/4:0

TG 4:0/4:0/4:0

C15H26O6 (302.1729)


   
   
   

RO-3

RO-3

C16H22N4O2 (302.1743)


RO-3 is a potent, CNS-penetrant, and orally active P2X3 and P2X2/3 antagonist with pIC50s of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. RO-3 shows selectivity for P2X3 and P2X2/3 over all other functional homomultimeric P2X receptors (IC50 >10?μM at P2X1,2,4,5,7)[1].

   

Tripeptide-32

Tripeptide-32

C12H22N4O5 (302.159)


Tripeptide-32isa bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   

(1s,2r,4r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

(1s,2r,4r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

C15H26O6 (302.1729)


   

n-[(3s)-2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

n-[(3s)-2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

C17H22N2O3 (302.163)


   

6-benzyl-3-isopropyl-1,4-dimethyl-1,4-diazepane-2,5,7-trione

6-benzyl-3-isopropyl-1,4-dimethyl-1,4-diazepane-2,5,7-trione

C17H22N2O3 (302.163)


   

(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

13-o-acetylbaptifoline

NA

C17H22N2O3 (302.163)


{"Ingredient_id": "HBIN001269","Ingredient_name": "13-o-acetylbaptifoline","Alias": "NA","Ingredient_formula": "C17H22N2O3","Ingredient_Smile": "CC(=O)OC1CCN2CC3CC(C2C1)CN4C3=CC=CC4=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "329","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acanthoine

NA

C16H22N4O2 (302.1743)


{"Ingredient_id": "HBIN014343","Ingredient_name": "acanthoine","Alias": "NA","Ingredient_formula": "C16H22N4O2","Ingredient_Smile": "COC1=C(C=C(C=C1)C=CC(C=CCN=CN)N=CN)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "81","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-hydroxy-2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

2-hydroxy-2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

C17H22N2O3 (302.163)


   

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

C22H22O (302.1671)


   

(1r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

(1r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

(2e,4e,6r)-6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

(2e,4e,6r)-6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

C15H26O4S (302.1552)


   

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   

n-hydroxy(2e,4e)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

n-hydroxy(2e,4e)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

C16H22N4O2 (302.1743)


   

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

C15H26O6 (302.1729)


   

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

C22H22O (302.1671)


   

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729)


   

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

C16H22N4O2 (302.1743)


   

(1s,3as,4r,8as)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

(1s,3as,4r,8as)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

C15H26O4S (302.1552)


   

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

C16H22N4O2 (302.1743)


   

2-hydroxy-2-methyl-n-{1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl}propanimidic acid

2-hydroxy-2-methyl-n-{1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl}propanimidic acid

C17H22N2O3 (302.163)


   

(1r,4s)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

(1r,4s)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

C15H26O4S (302.1552)


   

2,4-bis[(1r)-1-phenylethyl]phenol

2,4-bis[(1r)-1-phenylethyl]phenol

C22H22O (302.1671)


   

6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

n-(2-{3-[(1-hydroxyethylidene)amino]propanoyl}phenyl)-2,2-dimethylbut-3-enimidic acid

n-(2-{3-[(1-hydroxyethylidene)amino]propanoyl}phenyl)-2,2-dimethylbut-3-enimidic acid

C17H22N2O3 (302.163)


   

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

C15H26O6 (302.1729)


   

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

C16H22N4O2 (302.1743)


   

n-[2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

n-[2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

C17H22N2O3 (302.163)


   

n-hydroxy(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

n-hydroxy(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(1r,3as,4s,8ar)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

(1r,3as,4s,8ar)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid

C15H26O4S (302.1552)


   

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729)